nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR1B—dura mater—bone cancer	0.0786	0.22	CbGeAlD
Amoxapine—HTR1B—trigeminal nerve—bone cancer	0.0338	0.0944	CbGeAlD
Amoxapine—HTR3A—cranial nerve—bone cancer	0.0287	0.0802	CbGeAlD
Amoxapine—ORM1—vertebral column—bone cancer	0.0252	0.0704	CbGeAlD
Amoxapine—HRH1—nose—bone cancer	0.0248	0.0693	CbGeAlD
Amoxapine—HTR1B—cranial nerve—bone cancer	0.0241	0.0673	CbGeAlD
Amoxapine—HTR7—cranial nerve—bone cancer	0.0186	0.0519	CbGeAlD
Amoxapine—HTR2A—trigeminal nerve—bone cancer	0.0163	0.0454	CbGeAlD
Amoxapine—Paresthesia of limbs—Methotrexate—bone cancer	0.0129	0.0506	CcSEcCtD
Amoxapine—HRH4—bone marrow—bone cancer	0.012	0.0334	CbGeAlD
Amoxapine—HTR2A—cranial nerve—bone cancer	0.0116	0.0324	CbGeAlD
Amoxapine—HTR2A—vertebral column—bone cancer	0.0114	0.0317	CbGeAlD
Amoxapine—HTR2A—hindlimb—bone cancer	0.00976	0.0273	CbGeAlD
Amoxapine—HTR2A—appendage—bone cancer	0.00838	0.0234	CbGeAlD
Amoxapine—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.00777	0.0304	CcSEcCtD
Amoxapine—Asenapine—CYP3A4—bone cancer	0.00455	0.217	CrCbGaD
Amoxapine—Body temperature increased—Carboplatin—bone cancer	0.00434	0.017	CcSEcCtD
Amoxapine—Lacrimation—Epirubicin—bone cancer	0.00394	0.0154	CcSEcCtD
Amoxapine—HTR7—connective tissue—bone cancer	0.00383	0.0107	CbGeAlD
Amoxapine—Lacrimation—Doxorubicin—bone cancer	0.00365	0.0143	CcSEcCtD
Amoxapine—Nasal congestion—Cisplatin—bone cancer	0.0036	0.0141	CcSEcCtD
Amoxapine—ORM1—bone marrow—bone cancer	0.00353	0.00986	CbGeAlD
Amoxapine—ORM1—spinal cord—bone cancer	0.00352	0.00982	CbGeAlD
Amoxapine—Cerebrovascular accident—Cisplatin—bone cancer	0.00334	0.0131	CcSEcCtD
Amoxapine—HTR1B—spinal cord—bone cancer	0.0033	0.0092	CbGeAlD
Amoxapine—GABRA1—spinal cord—bone cancer	0.0033	0.0092	CbGeAlD
Amoxapine—SLC6A3—spinal cord—bone cancer	0.00327	0.00913	CbGeAlD
Amoxapine—HTR2C—spinal cord—bone cancer	0.00316	0.00882	CbGeAlD
Amoxapine—HTR2B—tendon—bone cancer	0.00308	0.0086	CbGeAlD
Amoxapine—Petechiae—Methotrexate—bone cancer	0.00301	0.0118	CcSEcCtD
Amoxapine—SLC6A4—spinal cord—bone cancer	0.003	0.00837	CbGeAlD
Amoxapine—HRH1—connective tissue—bone cancer	0.00286	0.008	CbGeAlD
Amoxapine—Petechiae—Epirubicin—bone cancer	0.00282	0.011	CcSEcCtD
Amoxapine—ADRA2A—connective tissue—bone cancer	0.00281	0.00785	CbGeAlD
Amoxapine—Pancreatitis—Cisplatin—bone cancer	0.00278	0.0109	CcSEcCtD
Amoxapine—Chlordiazepoxide—CYP3A4—bone cancer	0.00271	0.129	CrCbGaD
Amoxapine—HTR1A—spinal cord—bone cancer	0.00266	0.00743	CbGeAlD
Amoxapine—HTR7—tendon—bone cancer	0.00264	0.00736	CbGeAlD
Amoxapine—Petechiae—Doxorubicin—bone cancer	0.00261	0.0102	CcSEcCtD
Amoxapine—HTR7—spinal cord—bone cancer	0.00254	0.0071	CbGeAlD
Amoxapine—Vasculitis—Methotrexate—bone cancer	0.00254	0.00994	CcSEcCtD
Amoxapine—Olanzapine—CYP3A4—bone cancer	0.00253	0.121	CrCbGaD
Amoxapine—Lacrimation increased—Epirubicin—bone cancer	0.00252	0.00985	CcSEcCtD
Amoxapine—Acute coronary syndrome—Cisplatin—bone cancer	0.00249	0.00975	CcSEcCtD
Amoxapine—Myocardial infarction—Cisplatin—bone cancer	0.00248	0.0097	CcSEcCtD
Amoxapine—Stomatitis—Cisplatin—bone cancer	0.00246	0.00964	CcSEcCtD
Amoxapine—HTR2A—connective tissue—bone cancer	0.00239	0.00668	CbGeAlD
Amoxapine—Atrioventricular block—Epirubicin—bone cancer	0.00239	0.00936	CcSEcCtD
Amoxapine—Coordination abnormal—Epirubicin—bone cancer	0.00236	0.00925	CcSEcCtD
Amoxapine—Lacrimation increased—Doxorubicin—bone cancer	0.00233	0.00912	CcSEcCtD
Amoxapine—Gynaecomastia—Methotrexate—bone cancer	0.00222	0.00868	CcSEcCtD
Amoxapine—Atrioventricular block—Doxorubicin—bone cancer	0.00221	0.00866	CcSEcCtD
Amoxapine—Coordination abnormal—Doxorubicin—bone cancer	0.00218	0.00856	CcSEcCtD
Amoxapine—Tinnitus—Cisplatin—bone cancer	0.00211	0.00828	CcSEcCtD
Amoxapine—Mental disability—Epirubicin—bone cancer	0.00201	0.00788	CcSEcCtD
Amoxapine—Alopecia—Cisplatin—bone cancer	0.002	0.00785	CcSEcCtD
Amoxapine—HRH1—tendon—bone cancer	0.00197	0.0055	CbGeAlD
Amoxapine—Estazolam—CYP3A4—bone cancer	0.00196	0.0935	CrCbGaD
Amoxapine—Flatulence—Cisplatin—bone cancer	0.00194	0.00762	CcSEcCtD
Amoxapine—ADRA2A—tendon—bone cancer	0.00193	0.0054	CbGeAlD
Amoxapine—Vascular purpura—Epirubicin—bone cancer	0.00188	0.00737	CcSEcCtD
Amoxapine—ADRA2A—spinal cord—bone cancer	0.00186	0.00521	CbGeAlD
Amoxapine—Mental disability—Doxorubicin—bone cancer	0.00186	0.00729	CcSEcCtD
Amoxapine—Vision blurred—Cisplatin—bone cancer	0.00186	0.00728	CcSEcCtD
Amoxapine—Tremor—Cisplatin—bone cancer	0.00185	0.00724	CcSEcCtD
Amoxapine—Cerebrovascular accident—Methotrexate—bone cancer	0.00184	0.00719	CcSEcCtD
Amoxapine—Prazepam—CYP3A4—bone cancer	0.00181	0.086	CrCbGaD
Amoxapine—Increased appetite—Epirubicin—bone cancer	0.00179	0.00702	CcSEcCtD
Amoxapine—Leukopenia—Cisplatin—bone cancer	0.00177	0.00692	CcSEcCtD
Amoxapine—Purpura—Epirubicin—bone cancer	0.00175	0.00684	CcSEcCtD
Amoxapine—Vascular purpura—Doxorubicin—bone cancer	0.00174	0.00682	CcSEcCtD
Amoxapine—Cerebrovascular accident—Epirubicin—bone cancer	0.00172	0.00673	CcSEcCtD
Amoxapine—Convulsion—Cisplatin—bone cancer	0.00171	0.0067	CcSEcCtD
Amoxapine—Ataxia—Methotrexate—bone cancer	0.00169	0.00662	CcSEcCtD
Amoxapine—Increased appetite—Doxorubicin—bone cancer	0.00166	0.00649	CcSEcCtD
Amoxapine—HTR2A—tendon—bone cancer	0.00164	0.00459	CbGeAlD
Amoxapine—Oxazepam—CYP3A4—bone cancer	0.00163	0.0777	CrCbGaD
Amoxapine—Purpura—Doxorubicin—bone cancer	0.00162	0.00633	CcSEcCtD
Amoxapine—Temazepam—CYP3A4—bone cancer	0.00161	0.0767	CrCbGaD
Amoxapine—Oedema—Cisplatin—bone cancer	0.00161	0.00631	CcSEcCtD
Amoxapine—Cerebrovascular accident—Doxorubicin—bone cancer	0.00159	0.00622	CcSEcCtD
Amoxapine—HTR2A—spinal cord—bone cancer	0.00158	0.00443	CbGeAlD
Amoxapine—Ataxia—Epirubicin—bone cancer	0.00158	0.0062	CcSEcCtD
Amoxapine—Thrombocytopenia—Cisplatin—bone cancer	0.00158	0.00618	CcSEcCtD
Amoxapine—Tachycardia—Cisplatin—bone cancer	0.00157	0.00616	CcSEcCtD
Amoxapine—Eosinophilia—Methotrexate—bone cancer	0.00154	0.00603	CcSEcCtD
Amoxapine—Quetiapine—CYP3A4—bone cancer	0.00154	0.0732	CrCbGaD
Amoxapine—Anorexia—Cisplatin—bone cancer	0.00154	0.00601	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—bone cancer	0.00152	0.00597	CcSEcCtD
Amoxapine—Hypotension—Cisplatin—bone cancer	0.00151	0.00589	CcSEcCtD
Amoxapine—Ataxia—Doxorubicin—bone cancer	0.00146	0.00573	CcSEcCtD
Amoxapine—Paraesthesia—Cisplatin—bone cancer	0.00145	0.00566	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—bone cancer	0.00144	0.00564	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—bone cancer	0.00143	0.00561	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—bone cancer	0.00143	0.00559	CcSEcCtD
Amoxapine—Decreased appetite—Cisplatin—bone cancer	0.0014	0.00548	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—bone cancer	0.00139	0.00543	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—bone cancer	0.00135	0.00529	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—bone cancer	0.00134	0.00526	CcSEcCtD
Amoxapine—Diazepam—CYP3A4—bone cancer	0.00134	0.0637	CrCbGaD
Amoxapine—Eosinophilia—Doxorubicin—bone cancer	0.00133	0.00522	CcSEcCtD
Amoxapine—Feeling abnormal—Cisplatin—bone cancer	0.00133	0.0052	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—bone cancer	0.00132	0.00518	CcSEcCtD
Amoxapine—Clozapine—CYP3A4—bone cancer	0.00132	0.0629	CrCbGaD
Amoxapine—Pancreatitis—Doxorubicin—bone cancer	0.00132	0.00517	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—bone cancer	0.0013	0.00508	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—bone cancer	0.00129	0.00506	CcSEcCtD
Amoxapine—Body temperature increased—Cisplatin—bone cancer	0.00127	0.00499	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—bone cancer	0.00126	0.00495	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—bone cancer	0.00126	0.00495	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—bone cancer	0.00124	0.00487	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—bone cancer	0.00124	0.00487	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—bone cancer	0.00122	0.0048	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—bone cancer	0.00121	0.00474	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—bone cancer	0.0012	0.0047	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—bone cancer	0.00117	0.00458	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—bone cancer	0.00117	0.00458	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—bone cancer	0.00116	0.00456	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—bone cancer	0.00116	0.00454	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—bone cancer	0.00116	0.00454	CcSEcCtD
Amoxapine—Asthenia—Cisplatin—bone cancer	0.00116	0.00453	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—bone cancer	0.00112	0.00439	CcSEcCtD
Amoxapine—Diarrhoea—Cisplatin—bone cancer	0.0011	0.00432	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—bone cancer	0.0011	0.00431	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—bone cancer	0.00109	0.00425	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—bone cancer	0.00108	0.00422	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—bone cancer	0.00107	0.0042	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—bone cancer	0.00106	0.00415	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—bone cancer	0.00103	0.00403	CcSEcCtD
Amoxapine—Vomiting—Cisplatin—bone cancer	0.00102	0.00401	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—bone cancer	0.00102	0.004	CcSEcCtD
Amoxapine—Rash—Cisplatin—bone cancer	0.00102	0.00398	CcSEcCtD
Amoxapine—Dermatitis—Cisplatin—bone cancer	0.00101	0.00397	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—bone cancer	0.001	0.00393	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—bone cancer	0.000999	0.00391	CcSEcCtD
Amoxapine—Tension—Epirubicin—bone cancer	0.000995	0.0039	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—bone cancer	0.000993	0.00389	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—bone cancer	0.000984	0.00386	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—bone cancer	0.00097	0.0038	CcSEcCtD
Amoxapine—Nausea—Cisplatin—bone cancer	0.000957	0.00375	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—bone cancer	0.000955	0.00374	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—bone cancer	0.000952	0.00373	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—bone cancer	0.000938	0.00367	CcSEcCtD
Amoxapine—Agitation—Epirubicin—bone cancer	0.000931	0.00365	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—bone cancer	0.000924	0.00362	CcSEcCtD
Amoxapine—Tension—Doxorubicin—bone cancer	0.00092	0.0036	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—bone cancer	0.000918	0.0036	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—bone cancer	0.000911	0.00357	CcSEcCtD
Amoxapine—Syncope—Epirubicin—bone cancer	0.000909	0.00356	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—bone cancer	0.000907	0.00355	CcSEcCtD
Amoxapine—Palpitations—Epirubicin—bone cancer	0.000896	0.00351	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—bone cancer	0.000891	0.00349	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—bone cancer	0.000891	0.00349	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—bone cancer	0.000884	0.00346	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—bone cancer	0.000878	0.00344	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—bone cancer	0.000875	0.00343	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—bone cancer	0.000866	0.00339	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—bone cancer	0.000862	0.00338	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—bone cancer	0.000844	0.0033	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—bone cancer	0.000843	0.0033	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—bone cancer	0.000841	0.00329	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—bone cancer	0.00084	0.00329	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—bone cancer	0.000834	0.00327	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—bone cancer	0.000829	0.00325	CcSEcCtD
Amoxapine—Oedema—Epirubicin—bone cancer	0.000827	0.00324	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—bone cancer	0.000826	0.00323	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—bone cancer	0.000824	0.00323	CcSEcCtD
Amoxapine—Shock—Epirubicin—bone cancer	0.000814	0.00319	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—bone cancer	0.000813	0.00318	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—bone cancer	0.00081	0.00317	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—bone cancer	0.00081	0.00317	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—bone cancer	0.000807	0.00316	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—bone cancer	0.0008	0.00313	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—bone cancer	0.000794	0.00311	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—bone cancer	0.000789	0.00309	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—bone cancer	0.000786	0.00308	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—bone cancer	0.000781	0.00306	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—bone cancer	0.000778	0.00305	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—bone cancer	0.000773	0.00303	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—bone cancer	0.000772	0.00302	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—bone cancer	0.000768	0.00301	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—bone cancer	0.000765	0.003	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—bone cancer	0.000762	0.00298	CcSEcCtD
Amoxapine—Shock—Doxorubicin—bone cancer	0.000753	0.00295	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—bone cancer	0.000749	0.00293	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—bone cancer	0.000748	0.00293	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—bone cancer	0.000747	0.00293	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—bone cancer	0.000743	0.00291	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—bone cancer	0.000735	0.00288	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—bone cancer	0.00073	0.00286	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—bone cancer	0.000728	0.00285	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—bone cancer	0.000728	0.00285	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—bone cancer	0.000723	0.00283	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—bone cancer	0.000719	0.00282	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—bone cancer	0.000715	0.0028	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—bone cancer	0.000713	0.00279	CcSEcCtD
Amoxapine—Constipation—Epirubicin—bone cancer	0.000707	0.00277	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—bone cancer	0.000702	0.00275	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—bone cancer	0.000699	0.00274	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—bone cancer	0.000699	0.00274	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—bone cancer	0.000692	0.00271	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—bone cancer	0.000687	0.00269	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—bone cancer	0.000682	0.00267	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—bone cancer	0.00068	0.00266	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—bone cancer	0.000676	0.00265	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—bone cancer	0.000674	0.00264	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—bone cancer	0.000665	0.00261	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—bone cancer	0.00066	0.00258	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—bone cancer	0.000657	0.00257	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—bone cancer	0.000655	0.00256	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—bone cancer	0.000654	0.00256	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—bone cancer	0.000654	0.00256	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—bone cancer	0.000634	0.00248	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—bone cancer	0.000631	0.00247	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000626	0.00245	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—bone cancer	0.000625	0.00245	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—bone cancer	0.000608	0.00238	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—bone cancer	0.000605	0.00237	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—bone cancer	0.000605	0.00237	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—bone cancer	0.000605	0.00237	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—bone cancer	0.000594	0.00232	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—bone cancer	0.000585	0.00229	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—bone cancer	0.000585	0.00229	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—bone cancer	0.000566	0.00222	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—bone cancer	0.000562	0.0022	CcSEcCtD
Amoxapine—Rash—Methotrexate—bone cancer	0.000557	0.00218	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—bone cancer	0.000557	0.00218	CcSEcCtD
Amoxapine—Headache—Methotrexate—bone cancer	0.000554	0.00217	CcSEcCtD
Amoxapine—Asthenia—Doxorubicin—bone cancer	0.000549	0.00215	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—bone cancer	0.000547	0.00214	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—bone cancer	0.000542	0.00212	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—bone cancer	0.000526	0.00206	CcSEcCtD
Amoxapine—Nausea—Methotrexate—bone cancer	0.000525	0.00206	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—bone cancer	0.000524	0.00205	CcSEcCtD
Amoxapine—Rash—Epirubicin—bone cancer	0.000522	0.00204	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—bone cancer	0.000521	0.00204	CcSEcCtD
Amoxapine—Headache—Epirubicin—bone cancer	0.000518	0.00203	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—bone cancer	0.000506	0.00198	CcSEcCtD
Amoxapine—Nausea—Epirubicin—bone cancer	0.000491	0.00192	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—bone cancer	0.000487	0.00191	CcSEcCtD
Amoxapine—Rash—Doxorubicin—bone cancer	0.000483	0.00189	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—bone cancer	0.000482	0.00189	CcSEcCtD
Amoxapine—Headache—Doxorubicin—bone cancer	0.00048	0.00188	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—bone cancer	0.000455	0.00178	CcSEcCtD
Amoxapine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000181	0.000496	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.000181	0.000496	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SMO—bone cancer	0.000179	0.00049	CbGpPWpGaD
Amoxapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000179	0.000489	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RGS1—bone cancer	0.000178	0.000488	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GRM4—bone cancer	0.000178	0.000488	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—PLAU—bone cancer	0.000175	0.000478	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GRM1—bone cancer	0.000173	0.000473	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—GNA11—bone cancer	0.000171	0.000469	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—GNA11—bone cancer	0.000171	0.000468	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SMO—bone cancer	0.000171	0.000468	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL3—bone cancer	0.000171	0.000467	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GRM1—bone cancer	0.00017	0.000465	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GRM1—bone cancer	0.00017	0.000464	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GRM1—bone cancer	0.000169	0.000462	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	0.000169	0.000461	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	0.000168	0.000461	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL3—bone cancer	0.000168	0.00046	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL3—bone cancer	0.000168	0.000459	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL3—bone cancer	0.000167	0.000457	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.000166	0.000455	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—GNA11—bone cancer	0.000166	0.000455	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.000165	0.00045	CbGpPWpGaD
Amoxapine—DRD2—Circadian rythm related genes—TP53—bone cancer	0.000164	0.000449	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—GNA11—bone cancer	0.000164	0.000448	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SMO—bone cancer	0.000161	0.000441	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—TP53—bone cancer	0.000161	0.00044	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ATF1—bone cancer	0.000159	0.000436	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ATF1—bone cancer	0.000159	0.000435	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SMO—bone cancer	0.000159	0.000435	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—GNA11—bone cancer	0.000156	0.000428	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL3—bone cancer	0.000155	0.000425	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL3—bone cancer	0.000155	0.000424	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ATF1—bone cancer	0.000155	0.000423	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GRM1—bone cancer	0.000155	0.000423	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL3—bone cancer	0.000153	0.000418	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—KIT—bone cancer	0.000152	0.000417	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ATF1—bone cancer	0.000152	0.000416	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL3—bone cancer	0.000151	0.000413	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL3—bone cancer	0.000148	0.000406	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—GNA11—bone cancer	0.000147	0.000403	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—GNA11—bone cancer	0.000145	0.000398	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ATF1—bone cancer	0.000145	0.000398	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—BRAF—bone cancer	0.000143	0.000392	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL3—bone cancer	0.000142	0.000388	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—EGFR—bone cancer	0.000139	0.00038	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SMO—bone cancer	0.000139	0.000379	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SMO—bone cancer	0.000138	0.000377	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ENO2—bone cancer	0.000137	0.000376	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ATF1—bone cancer	0.000137	0.000375	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ATF1—bone cancer	0.000135	0.00037	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL3—bone cancer	0.000134	0.000366	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFBR2—bone cancer	0.000133	0.000363	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFBR2—bone cancer	0.000133	0.000363	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL3—bone cancer	0.000132	0.000361	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFBR2—bone cancer	0.000129	0.000353	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—DHFR—bone cancer	0.000128	0.000349	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFBR2—bone cancer	0.000127	0.000347	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—GNA11—bone cancer	0.000127	0.000347	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000126	0.000345	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IGF1R—bone cancer	0.000125	0.000342	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IGF1R—bone cancer	0.000125	0.000341	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SMO—bone cancer	0.000122	0.000333	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IGF1R—bone cancer	0.000121	0.000332	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	0.000121	0.000332	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MDM2—bone cancer	0.00012	0.000328	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SMO—bone cancer	0.00012	0.000328	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SMO—bone cancer	0.00012	0.000327	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF1R—bone cancer	0.000119	0.000327	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GNA11—bone cancer	0.000119	0.000326	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SMO—bone cancer	0.000119	0.000326	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ATF1—bone cancer	0.000118	0.000322	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000117	0.000321	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000117	0.000321	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL3—bone cancer	0.000115	0.000314	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000114	0.000313	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000114	0.000313	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1R—bone cancer	0.000114	0.000312	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFBR2—bone cancer	0.000113	0.000309	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000111	0.000305	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.00011	0.0003	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000109	0.000299	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000109	0.000298	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GNA11—bone cancer	0.000109	0.000298	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000108	0.000296	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1R—bone cancer	0.000108	0.000294	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.000107	0.000293	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1R—bone cancer	0.000106	0.00029	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—JUN—bone cancer	0.000104	0.000285	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000103	0.000283	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000102	0.000279	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ATF1—bone cancer	0.000102	0.000278	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MMP9—bone cancer	0.000101	0.000278	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000101	0.000277	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL3—bone cancer	0.000101	0.000276	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ATF1—bone cancer	9.97e-05	0.000273	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GNA11—bone cancer	9.97e-05	0.000273	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL3—bone cancer	9.93e-05	0.000272	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL3—bone cancer	9.91e-05	0.000271	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL3—bone cancer	9.88e-05	0.00027	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	9.83e-05	0.000269	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	9.78e-05	0.000268	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL3—bone cancer	9.72e-05	0.000266	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ATF1—bone cancer	9.26e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1R—bone cancer	9.25e-05	0.000253	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GSTP1—bone cancer	9.24e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1R—bone cancer	9.2e-05	0.000252	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KIT—bone cancer	9.06e-05	0.000248	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KIT—bone cancer	9.05e-05	0.000248	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL3—bone cancer	9.03e-05	0.000247	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ENO2—bone cancer	8.96e-05	0.000245	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KIT—bone cancer	8.81e-05	0.000241	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KIT—bone cancer	8.67e-05	0.000237	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFBR2—bone cancer	8.63e-05	0.000236	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—BRAF—bone cancer	8.52e-05	0.000233	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—BRAF—bone cancer	8.51e-05	0.000233	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	8.49e-05	0.000232	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFBR2—bone cancer	8.48e-05	0.000232	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	8.45e-05	0.000231	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	8.32e-05	0.000227	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—DHFR—bone cancer	8.31e-05	0.000227	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—BRAF—bone cancer	8.28e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KIT—bone cancer	8.27e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—EGFR—bone cancer	8.26e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—EGFR—bone cancer	8.25e-05	0.000226	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EGFR—bone cancer	8.2e-05	0.000224	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—BRAF—bone cancer	8.15e-05	0.000223	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1R—bone cancer	8.12e-05	0.000222	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—EGFR—bone cancer	8.02e-05	0.000219	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1R—bone cancer	7.99e-05	0.000219	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1R—bone cancer	7.97e-05	0.000218	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1R—bone cancer	7.95e-05	0.000217	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—EGFR—bone cancer	7.9e-05	0.000216	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	7.82e-05	0.000214	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KIT—bone cancer	7.8e-05	0.000213	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—BRAF—bone cancer	7.78e-05	0.000213	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GNA11—bone cancer	7.77e-05	0.000212	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	7.73e-05	0.000211	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KIT—bone cancer	7.7e-05	0.000211	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—EGFR—bone cancer	7.54e-05	0.000206	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—BRAF—bone cancer	7.33e-05	0.000201	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	7.27e-05	0.000199	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—BRAF—bone cancer	7.24e-05	0.000198	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MDM2—bone cancer	7.14e-05	0.000195	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MDM2—bone cancer	7.13e-05	0.000195	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—EGFR—bone cancer	7.11e-05	0.000194	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CYP3A4—bone cancer	7.04e-05	0.000193	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—bone cancer	7.03e-05	0.000192	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—EGFR—bone cancer	7.01e-05	0.000192	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MDM2—bone cancer	6.94e-05	0.00019	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—bone cancer	6.89e-05	0.000188	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MDM2—bone cancer	6.82e-05	0.000187	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KIT—bone cancer	6.71e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KIT—bone cancer	6.67e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MDM2—bone cancer	6.52e-05	0.000178	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—BRAF—bone cancer	6.31e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—BRAF—bone cancer	6.27e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—JUN—bone cancer	6.2e-05	0.00017	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—JUN—bone cancer	6.2e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MDM2—bone cancer	6.14e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—EGFR—bone cancer	6.11e-05	0.000167	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—EGFR—bone cancer	6.08e-05	0.000166	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MDM2—bone cancer	6.06e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MMP9—bone cancer	6.04e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MMP9—bone cancer	6.03e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—JUN—bone cancer	6.03e-05	0.000165	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTP1—bone cancer	6.02e-05	0.000165	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—JUN—bone cancer	5.93e-05	0.000162	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KIT—bone cancer	5.89e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—bone cancer	5.87e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KIT—bone cancer	5.8e-05	0.000159	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KIT—bone cancer	5.78e-05	0.000158	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—bone cancer	5.77e-05	0.000158	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KIT—bone cancer	5.76e-05	0.000158	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KIT—bone cancer	5.67e-05	0.000155	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—JUN—bone cancer	5.66e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—BRAF—bone cancer	5.54e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—bone cancer	5.51e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—BRAF—bone cancer	5.45e-05	0.000149	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—BRAF—bone cancer	5.44e-05	0.000149	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—BRAF—bone cancer	5.42e-05	0.000148	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—bone cancer	5.37e-05	0.000147	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—JUN—bone cancer	5.34e-05	0.000146	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—BRAF—bone cancer	5.33e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MDM2—bone cancer	5.28e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—bone cancer	5.28e-05	0.000144	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KIT—bone cancer	5.27e-05	0.000144	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—JUN—bone cancer	5.27e-05	0.000144	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—bone cancer	5.27e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MDM2—bone cancer	5.26e-05	0.000144	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—bone cancer	5.25e-05	0.000144	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—bone cancer	5.2e-05	0.000142	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	5.17e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—bone cancer	5.13e-05	0.00014	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—BRAF—bone cancer	4.96e-05	0.000136	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—bone cancer	4.88e-05	0.000133	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—bone cancer	4.87e-05	0.000133	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	4.8e-05	0.000131	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—bone cancer	4.79e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—bone cancer	4.74e-05	0.00013	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—bone cancer	4.66e-05	0.000128	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MDM2—bone cancer	4.64e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—JUN—bone cancer	4.59e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—JUN—bone cancer	4.57e-05	0.000125	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MDM2—bone cancer	4.56e-05	0.000125	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MDM2—bone cancer	4.55e-05	0.000125	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MDM2—bone cancer	4.54e-05	0.000124	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MDM2—bone cancer	4.47e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—bone cancer	4.47e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—bone cancer	4.45e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—bone cancer	4.44e-05	0.000122	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—bone cancer	4.2e-05	0.000115	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MDM2—bone cancer	4.15e-05	0.000114	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—bone cancer	4.14e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—bone cancer	4.1e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—bone cancer	4.09e-05	0.000112	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JUN—bone cancer	4.03e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—bone cancer	3.98e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JUN—bone cancer	3.97e-05	0.000109	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JUN—bone cancer	3.96e-05	0.000108	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JUN—bone cancer	3.95e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—bone cancer	3.92e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—bone cancer	3.92e-05	0.000107	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JUN—bone cancer	3.88e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—bone cancer	3.86e-05	0.000106	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—bone cancer	3.85e-05	0.000105	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—bone cancer	3.84e-05	0.000105	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—bone cancer	3.78e-05	0.000103	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—bone cancer	3.74e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—bone cancer	3.61e-05	9.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JUN—bone cancer	3.61e-05	9.87e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—bone cancer	3.59e-05	9.82e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—bone cancer	3.53e-05	9.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—bone cancer	3.51e-05	9.61e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—bone cancer	3.48e-05	9.51e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—bone cancer	3.17e-05	8.67e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—bone cancer	3.12e-05	8.53e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—bone cancer	3.12e-05	8.53e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—bone cancer	3.11e-05	8.51e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—bone cancer	3.1e-05	8.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—bone cancer	3.05e-05	8.35e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—bone cancer	3.03e-05	8.29e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—bone cancer	3.02e-05	8.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—bone cancer	2.84e-05	7.76e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—bone cancer	2.66e-05	7.28e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—bone cancer	2.62e-05	7.16e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—bone cancer	2.61e-05	7.15e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—bone cancer	2.6e-05	7.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—bone cancer	2.56e-05	7.01e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—bone cancer	2.38e-05	6.52e-05	CbGpPWpGaD
